

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Protease-activated receptors are a family of G-protein-coupled receptors implicated in inflammation, cell differentiation and proliferation. AZ3451 is an inhibitor of wild-type protease-activated receptor 2 (PAR2) with an IC50 value of 23 nM. AZ3451 also showed inhibitory effect on PAR2s with a single-point mutation on N222Q, H227A, H227Q, D228A, D228N, H135Y, I327L, G157M, Y210L, and F154A with IC50 values of 12, 12, 25, 23, 4.3, 20, 32, 780, 570 and 370 nM, respectively. In 1321N1 cells overexpressing wild-type human PAR2, stimulation of 1321N1 with SLIGRL led to the phosphorylation of extracellular signal-regulated kinase (ERK), whereas the induction of ERK phosphorylation was completely inhibited by AZ3451 at the concentration of 10 μM. The IP-One HTRF assay in 1321N1 cells stably expressing human PAR2 showed that the IC50 value of AZ3451 was 23nM vs. SLIGRL. The FLIPR assay showed that the IC50 values of AZ3451 were 5.4 nM and 6.6 nM against SLIGRL and trypsin, respectively[1]. |
| 作用机制 | AZ3451 is an antagonist of PAR2 that binds to a remote allosteric site outside the helical bundle of the receptor, preventing structural rearrangements required for receptor activation[1]. |
| Concentration | Treated Time | Description | References | |
| HUVEC cells | 10 μM | 1 hour | To investigate the effect of AZ3451 on CHI3L1/PAR2 signaling in HUVEC cells, results showed AZ3451 attenuated AICAR-induced HUVEC tubule formation and upregulation of CHI3L1/PAR2. | Biomedicines. 2022 Apr 29;10(5):1028 |
| rat chondrocytes | 10 μM | 48 h | AZ3451 suppressed IL-1β-induced inflammation response, cartilage degradation and premature senescence. | Aging (Albany NY). 2019 Dec 16;11(24):12532-12545 |
| Administration | Dosage | Frequency | Description | References | ||
| Sprague Dawley rats | Hyperuricemia model | Intraperitoneal injection | 1 mg/kg | Daily for 6 weeks | To evaluate the protective effect of AZ3451 on hyperuricemia-induced renal injury. Results showed that AZ3451 significantly attenuated tubular dilatation and tubulointerstitial inflammatory cell infiltration, reduced serum creatinine and BUN levels, and significantly decreased serum KIM-1 and NGAL levels. | Mediators Inflamm. 2023 Jul 13;2023:5007488 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.75mL 0.35mL 0.17mL |
8.75mL 1.75mL 0.87mL |
17.50mL 3.50mL 1.75mL |
|
| CAS号 | 2100284-59-9 |
| 分子式 | C30H27BrN4O3 |
| 分子量 | 571.46 |
| SMILES Code | O=C(C1=CC=C2C(N=C(C3=C(Br)C=C(OCO4)C4=C3)N2[C@H](C5CCCCC5)C)=C1)NC6=CC=C(C#N)C=C6 |
| MDL No. | MFCD31728469 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | FJAOGFGHTPYADT-SFHVURJKSA-N |
| Pubchem ID | 126961335 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(183.74 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1